Company: KROS
Filing Date: 2025-06-09
Form Type: 8-K
Source: 0001664710-25-000057
Chunk: 3

Company: Keros Therapeutics, Inc.
Filing Date: 2025-06-09
Form: 8-K
Item: Item 9.01
Chunk 3
---
Item 9.01 Financial Statements and Exhibits.

(d) Exhibits

  Exhibit                                                                                                                
  No.          Description                                                                                               
  99.1         Press Release dated June 9, 2025.                                                                         
  104          Cover Page Interactive Data File (the cover page XBRL tags are embedded within the Inline XBRL document)  

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

  KEROS THERAPEUTICS, INC.                               
  By:                           /s/ Jasbir Seehra        
                                Jasbir Seehra, Ph. D.    

Dated: June 9, 2025